Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV

Abstract Introduction In Mexico, HIV genotyping is performed in people living with HIV (PLWH) failing their first-line antiretroviral (ARV) regimen; it is not routinely done for all treatment-naive PLWH before ARV initiation. The first nationally representative survey published in 2016 reported that...

Descripció completa

Dades bibliogràfiques

Autors principals:	Samantha Climaco-Arvizu, Víctor Flores-López, Carolina González-Torres, Francisco Javier Gaytán-Cervantes, María Concepción Hernández-García, Paola Berenice Zárate-Segura, Monserrat Chávez-Torres, Emiliano Tesoro-Cruz, Sandra María Pinto-Cardoso, Vilma Carolina Bekker-Méndez
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-05-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Human immunodeficiency virus Antiretroviral therapy HIV drug resistance mutations HIV genotyping Gag Protease
Accés en línia:	https://doi.org/10.1186/s12879-022-07446-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!